This is a mandatory sell-to-cover for RSU tax withholding, not a discretionary insider sale. No negative signal. Monitor for any future Form 4 filings showing discretionary open-market sales by officers, which would carry more weight.
Price Chart
Executive Summary
Lillie James Woodruff, an officer of MapLight Therapeutics, filed a Form 144 notice of intent to sell 11,513 shares of common stock, with an estimated aggregate market value of approximately $89,917. The shares are held through a trust managed by James Lillie and are being sold solely to satisfy tax-withholding obligations related to restricted stock unit (RSU) vesting. This is a routine, mandatory sell-to-cover transaction, not a discretionary insider sale, and carries minimal signaling value.
Key Facts
- Insider Lillie James Woodruff (Officer) filed Form 144 on 2026-10-15 to sell 11,513 shares of MapLight Therapeutics common stock.
- Estimated aggregate market value of the proposed sale is $89,916.53, based on a price of approximately $7.81 per share.
- The sale is explicitly described as being solely to satisfy tax-withholding obligations in connection with RSU vesting.
- The shares are held in a trust managed by James Lillie, and the filing covers sales executed on July 15, 16, 17, and August 3, 2026, totaling 40,349 shares at varying prices.
- The filing references RSU grants from May 2024, July 2023, July 2025, November 2023, and October 2025 as the source of the shares.
- The company's market cap is approximately $4.485 billion (based on 448,500,000 shares outstanding at the filing date).
Financial Impact
Proposed sale of 11,513 shares valued at ~$89,917, representing less than 0.003% of shares outstanding. The total shares sold in the covered period (40,349 shares, ~$315,000) are also immaterial relative to market cap.
Risk Factors
- None from this filing — the sale is mandatory and pre-arranged for tax purposes.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001974158-26-000104 |
| Document: 0001974158-26-000104-index.html | 0001974158-26-000104 |
| Document: 0001974158-26-000104.txt | 0001974158-26-000104 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $8.17 (−2.13%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $8.17 (+6.10%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $8.17 (+6.10%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $8.17 (+6.10%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $8.17 (−24.07%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $8.17 (−25.05%) |
Aug 4, 2026 11w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $8.17 (−36.76%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $8.17 (−36.86%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $8.17 (+37.25%) |
Jul 28, 2026 12w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $8.17 (−45.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers